- Home
- ESLT vs ASND Comparison
ESLT vs ASND Comparison
Compare ESLT & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESLT | ASND |
|---|---|---|
| Founded | 1966 | 2006 |
| Country | Israel | Denmark |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.8B | 12.8B |
| IPO Year | 1996 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ESLT | ASND |
|---|---|---|
| Price | $591.88 | $212.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 15 |
| Target Price | ★ $550.33 | $256.40 |
| AVG Volume (30 Days) | 106.4K | ★ 708.6K |
| Earning Date | 11-18-2025 | 02-11-2026 |
| Dividend Yield | ★ 0.46% | N/A |
| EPS Growth | ★ 68.63 | N/A |
| EPS | ★ 9.87 | N/A |
| Revenue | ★ $7,720,284,000.00 | $758,592,045.00 |
| Revenue This Year | $18.47 | $98.90 |
| Revenue Next Year | $10.93 | $83.74 |
| P/E Ratio | $59.51 | ★ N/A |
| Revenue Growth | 18.35 | ★ 97.46 |
| 52 Week Low | $258.71 | $118.03 |
| 52 Week High | $593.00 | $229.94 |
Technical Indicators
Market Signals| Indicator | ESLT | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 77.74 | 54.32 |
| Support Level | $574.29 | $207.28 |
| Resistance Level | $584.45 | $216.19 |
| Average True Range (ATR) | 11.27 | 8.23 |
| MACD | 4.05 | 0.50 |
| Stochastic Oscillator | 99.23 | 47.26 |
Price Performance
Historical ComparisonAbout ESLT Elbit Systems Ltd.
Elbit Systems Ltd is a technology company involved in producing a portfolio of systems and products for aircraft, land, and naval applications. The company's products are used for defense, homeland security, and commercial flight capabilities. Its systems and solutions may be installed on new platforms, or it may perform a comprehensive modernization program to transform a platform. Elbit Systems gives instructions to its customers on the proper maintenance of its products and will provide support team specialists when the customer cannot fix a problem. The company markets its systems and products as a prime contractor or as a subcontractor to government, defense, and homeland security contractors world wide.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.